longtext: 2BAG-pdb

content
HEADER    HYDROLASE                               14-OCT-05   2BAG
TITLE     3D STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE
TITLE    2 COMPLEXED WITH GANSTIGMINE
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: ACETYLCHOLINESTERASE;
COMPND   3 CHAIN: A;
COMPND   4 SYNONYM: ACHE;
COMPND   5 EC: 3.1.1.7
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA;
SOURCE   3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY;
SOURCE   4 VARIANT: G2 FORM;
SOURCE   5 ORGAN: ELETRIC ORGAN;
SOURCE   6 TISSUE: ELECTROPLAQUE
KEYWDS    SERINE HYDROLASE, CHOLINESTERASE, NEUROTRANSMITTER CLEAVAGE,
KEYWDS   2 ANTI-ALZHEIMER DRUG
EXPDTA    X-RAY DIFFRACTION
AUTHOR    D.LAMBA,C.BARTOLUCCI,M.SIOTTO,M.RACCHI,G.VILLETTI,
AUTHOR   2 M.DELCANALE
REVDAT   1   29-AUG-06 2BAG    0
JRNL        AUTH   C.BARTOLUCCI,M.SIOTTO,E.GHIDINI,G.AMARI,
JRNL        AUTH 2 P.T.BOLZONI,M.RACCHI,G.VILLETTI,M.DELCANALE,D.LAMBA
JRNL        TITL   STRUCTURAL DETERMINANTS OF TORPEDO CALIFORNICA
JRNL        TITL 2 ACETYLCHOLINESTERASE INHIBITION BY THE NOVEL AND
JRNL        TITL 3 ORALLY ACTIVE CARBAMATE BASED ANTI-ALZHEIMER DRUG
JRNL        TITL 4 GANSTIGMINE (CHF-2819)
JRNL        REF    J.MED.CHEM.                   V.  49  5051 2006
JRNL        REFN   ASTM JMCMAR  US ISSN 0022-2623
REMARK   1
REMARK   1 REFERENCE 1
REMARK   1  AUTH   C.BARTOLUCCI,E.PEROLA,L.CELLAI,M.BRUFANI,D.LAMBA
REMARK   1  TITL   BACK DOOR OPENING IMPLIED BY THE CRYSTAL STRUCTURE
REMARK   1  TITL 2 OF A CARBAMOYLATED ACETYLCHOLINESTERASE
REMARK   1  REF    BIOCHEMISTRY                  V.  38  5714 1999
REMARK   1  REFN   ASTM BICHAW  US ISSN 0006-2960
REMARK   1 REFERENCE 2
REMARK   1  AUTH   P.BAR-ON,C.B.MILLARD,M.HAREL,H.DVIR,A.ENZ,
REMARK   1  AUTH 2 J.L.SUSSMAN,I.SILMAN
REMARK   1  TITL   KINETIC AND STRUCTURAL STUDIES ON THE INTERACTION
REMARK   1  TITL 2 OF CHOLINESTERASES WITH THE ANTI-ALZHEIMER DRUG
REMARK   1  TITL 3 RIVASTIGMINE
REMARK   1  REF    BIOCHEMISTRY                  V.  41  3555 2002
REMARK   1  REFN   ASTM BICHAW  US ISSN 0006-2960
REMARK   1 REFERENCE 3
REMARK   1  AUTH   E.PEROLA,L.CELLAI,D.LAMBA,L.FILOCAMO,M.BRUFANI
REMARK   1  TITL   LONG CHAIN ANALOGS OF PHYSOSTIGMINE AS POTENTIAL
REMARK   1  TITL 2 DRUGS FOR ALZHEIMER'S DISEASE: NEW INSIGHTS INTO
REMARK   1  TITL 3 THE MECHANISM OF ACTION IN THE INHIBITION OF
REMARK   1  TITL 4 ACETYLCHOLINESTERASE
REMARK   1  REF    BIOCHIM.BIOPHYS.ACTA          V.1343    41 1997
REMARK   1  REFN   ASTM BBACAQ  NE ISSN 0006-3002
REMARK   2
REMARK   2 RESOLUTION. 2.40 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : CNS 1.1
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,
REMARK   3               : READ,RICE,SIMONSON,WARREN
REMARK   3
REMARK   3  REFINEMENT TARGET : ENGH & HUBER
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 27.93
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 1599796.360
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 96.5
REMARK   3   NUMBER OF REFLECTIONS             : 37576
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE            (WORKING SET) : 0.190
REMARK   3   FREE R VALUE                     : 0.236
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.000
REMARK   3   FREE R VALUE TEST SET COUNT      : 3762
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.004
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 6
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.40
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.55
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 10.20
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 5470
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2240
REMARK   3   BIN FREE R VALUE                    : 0.2900
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 10.20
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 624
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.012
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 4244
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 79
REMARK   3   SOLVENT ATOMS            : 274
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 35.30
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 45.60
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 11.10000
REMARK   3    B22 (A**2) : 11.10000
REMARK   3    B33 (A**2) : -22.19000
REMARK   3    B12 (A**2) : 7.30000
REMARK   3    B13 (A**2) : 0.00000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.25
REMARK   3   ESD FROM SIGMAA              (A) : 0.21
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00
REMARK   3
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.32
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.31
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3   BOND LENGTHS                 (A) : 0.010
REMARK   3   BOND ANGLES            (DEGREES) : 1.60
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 23.40
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.95
REMARK   3
REMARK   3  ISOTROPIC THERMAL MODEL : OVERALL ANISOTROPIC
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK   3   MAIN-CHAIN BOND              (A**2) : 3.079 ; NULL
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 4.011 ; NULL
REMARK   3   SIDE-CHAIN BOND              (A**2) : 5.077 ; NULL
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 6.080 ; NULL
REMARK   3
REMARK   3  BULK SOLVENT MODELING.
REMARK   3   METHOD USED : FLAT MODEL
REMARK   3   KSOL        : 0.36
REMARK   3   BSOL        : 50.11
REMARK   3
REMARK   3  NCS MODEL : NULL
REMARK   3
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL
REMARK   3
REMARK   3  PARAMETER FILE  1  : NULL
REMARK   3  TOPOLOGY FILE  1   : NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 2BAG COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-OCT-2005.
REMARK 100 THE RCSB ID CODE IS RCSB034876.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 31-MAY-1998
REMARK 200  TEMPERATURE           (KELVIN) : 100.0
REMARK 200  PH                             : 6.00
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : ELETTRA
REMARK 200  BEAMLINE                       : 5.2R
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.00
REMARK 200  MONOCHROMATOR                  : DOUBLE CRYSTAL (SI111)
REMARK 200  OPTICS                         : THREE-SEGMENT PT-COATED
REMARK 200                                   TOROIDAL MIRROR
REMARK 200
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 37817
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.400
REMARK 200  RESOLUTION RANGE LOW       (A) : 27.930
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 96.4
REMARK 200  DATA REDUNDANCY                : 6.000
REMARK 200  R MERGE                    (I) : 0.06300
REMARK 200  R SYM                      (I) : 0.05700
REMARK 200   FOR THE DATA SET  : 8.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.44
REMARK 200  COMPLETENESS FOR SHELL     (%) : 97.4
REMARK 200  DATA REDUNDANCY IN SHELL       : 5.10
REMARK 200  R MERGE FOR SHELL          (I) : 0.47000
REMARK 200  R SYM FOR SHELL            (I) : 0.42200
REMARK 200   FOR SHELL         : 1.900
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 2ACE
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 69.20
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.00
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 40% PEG200, 100MM MES, PH 6.0,
REMARK 280  VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -Y,X-Y,1/3+Z
REMARK 290       3555   -X+Y,-X,2/3+Z
REMARK 290       4555   Y,X,-Z
REMARK 290       5555   X-Y,-Y,2/3-Z
REMARK 290       6555   -X,-X+Y,1/3-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       45.60800
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       91.21600
REMARK 290   SMTRY1   4 -0.500000  0.866025  0.000000        0.00000
REMARK 290   SMTRY2   4  0.866025  0.500000  0.000000        0.00000
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   5  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   5  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   5  0.000000  0.000000 -1.000000       91.21600
REMARK 290   SMTRY1   6 -0.500000 -0.866025  0.000000        0.00000
REMARK 290   SMTRY2   6 -0.866025  0.500000  0.000000        0.00000
REMARK 290   SMTRY3   6  0.000000  0.000000 -1.000000       45.60800
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT
REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR
REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S).
REMARK 350
REMARK 350 GENERATING THE BIOMOLECULE
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 350   BIOMT1   2 -0.500000  0.866025  0.000000        0.00000
REMARK 350   BIOMT2   2  0.866025  0.500000  0.000000        0.00000
REMARK 350   BIOMT3   2  0.000000  0.000000 -1.000000      136.82400
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     ASP A     1
REMARK 465     ASP A     2
REMARK 465     HIS A     3
REMARK 465     ALA A   536
REMARK 465     CYS A   537
REMARK 465     ASP A   538
REMARK 465     GLY A   539
REMARK 465     GLU A   540
REMARK 465     LEU A   541
REMARK 465     SER A   542
REMARK 465     SER A   543
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991
REMARK 500
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION
REMARK 500    MET A  90   SD    MET A  90   CE     0.062
REMARK 500    MET A 175   SD    MET A 175   CE    -0.162
REMARK 500    MET A 308   SD    MET A 308   CE     0.095
REMARK 500    MET A 379   SD    MET A 379   CE     0.073
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991
REMARK 500
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3
REMARK 500    ASP A  93   N   -  CA  -  C   ANGL. DEV. = -9.7 DEGREES
REMARK 500    ASN A 183   N   -  CA  -  C   ANGL. DEV. = 10.6 DEGREES
REMARK 500    ASP A 285   N   -  CA  -  C   ANGL. DEV. =-15.1 DEGREES
REMARK 500    ILE A 296   N   -  CA  -  C   ANGL. DEV. =-10.3 DEGREES
REMARK 500    GLY A 328   N   -  CA  -  C   ANGL. DEV. = 10.4 DEGREES
REMARK 500    GLY A 335   N   -  CA  -  C   ANGL. DEV. = 10.0 DEGREES
REMARK 500    GLY A 449   N   -  CA  -  C   ANGL. DEV. = 10.1 DEGREES
REMARK 500    TRP A 492   N   -  CA  -  C   ANGL. DEV. =-10.1 DEGREES
REMARK 500    LEU A 494   CA  -  CB  -  CG  ANGL. DEV. = 12.5 DEGREES
REMARK 500    ASP A 504   N   -  CA  -  C   ANGL. DEV. = -9.6 DEGREES
REMARK 600
REMARK 600 HETEROGEN
REMARK 600 THE STRUCTURE HAS BEEN DETERMINED BY SOAKING NATIVE
REMARK 600 ACHE CRYSTALS WITH THE COMPOUND GANSTIGMINE.
REMARK 600 IN THE CRYSTAL, SER200 IS ACYLATED AND THE LEAVING
REMARK 600 GROUP OF THE REACTION, GENESEROLINE, NOT BEING RETAINED
REMARK 600 IN THE ENZYME ACTIVE SITE.
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1OCE   RELATED DB: PDB
REMARK 900 ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA COMPLEXED
REMARK 900 WITH MF268
REMARK 900 RELATED ID: 1GQR   RELATED DB: PDB
REMARK 900 ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA COMPLEXED
REMARK 900 WITH RIVASTIGMINE
REMARK 900 RELATED ID: 1GQS   RELATED DB: PDB
REMARK 900 ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA COMPLEXED
REMARK 900 WITH 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL
REMARK 900 RELATED ID: 1EA5   RELATED DB: PDB
REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA AT 1.8
DBREF  2BAG A    1   543  UNP    P04058   ACES_TORCA      22    564
SEQRES   1 A  543  ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY
SEQRES   2 A  543  LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS
SEQRES   3 A  543  ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO
SEQRES   4 A  543  VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS
SEQRES   5 A  543  PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN
SEQRES   6 A  543  ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE
SEQRES   7 A  543  SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER
SEQRES   8 A  543  GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO
SEQRES   9 A  543  ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY
SEQRES  10 A  543  GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR
SEQRES  11 A  543  ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU
SEQRES  12 A  543  VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU
SEQRES  13 A  543  ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY
SEQRES  14 A  543  LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP
SEQRES  15 A  543  ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR
SEQRES  16 A  543  ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET
SEQRES  17 A  543  HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG
SEQRES  18 A  543  ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA
SEQRES  19 A  543  SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU
SEQRES  20 A  543  LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU
SEQRES  21 A  543  GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU
SEQRES  22 A  543  LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER
SEQRES  23 A  543  ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU
SEQRES  24 A  543  PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY
SEQRES  25 A  543  ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS
SEQRES  26 A  543  ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY
SEQRES  27 A  543  PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP
SEQRES  28 A  543  PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN
SEQRES  29 A  543  ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP
SEQRES  30 A  543  TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY
SEQRES  31 A  543  LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO
SEQRES  32 A  543  LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN
SEQRES  33 A  543  GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN
SEQRES  34 A  543  LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR
SEQRES  35 A  543  GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU
SEQRES  36 A  543  LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG
SEQRES  37 A  543  ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN
SEQRES  38 A  543  PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU
SEQRES  39 A  543  PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR
SEQRES  40 A  543  GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET
SEQRES  41 A  543  CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN
SEQRES  42 A  543  ALA THR ALA CYS ASP GLY GLU LEU SER SER
MODRES 2BAG ASN A   59  ASN  GLYCOSYLATION SITE
MODRES 2BAG ASN A  416  ASN  GLYCOSYLATION SITE
HET    NAG  A1059      14
HET    NAG  A1416      14
HET    1PE    301      16
HET    GSG  A1200      11
HET    MES    501      12
HET    MES    502      12
HETNAM     NAG N-ACETYL-D-GLUCOSAMINE
HETNAM     1PE PENTAETHYLENE GLYCOL
HETNAM     GSG 1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-
HETNAM   2 GSG  HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-
HETNAM   3 GSG  ETHYLPHENYLCARBAMATE
HETNAM     MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
HETSYN     NAG NAG
HETSYN     1PE PEG400
HETSYN     GSG GANSTIGMINE; (-)-(3AS,8AS,1S)-1,2,3,3A,8A-HEXAHYDRO-1,
HETSYN   2 GSG  3A,8-TRIMETHYLPYRROLO[2,3-B]INDOL-5-OL-2'-
HETSYN   3 GSG  ETHYLPHENYLCARBAMATE N-OXIDE HYDROCHLORIDE
FORMUL   2  NAG    2(C8 H15 N1 O6)
FORMUL   4  1PE    C10 H22 O6
FORMUL   5  GSG    C22 H27 N3 O3
FORMUL   6  MES    2(C6 H13 N1 O4 S1)
FORMUL   8  HOH   *274(H2 O1)
HELIX    1   1 VAL A   40  ARG A   44  5                                   5
HELIX    2   2 PHE A   78  MET A   83  1                                   6
HELIX    3   3 LEU A  127  ASN A  131  5                                   5
HELIX    4   4 GLY A  132  GLU A  140  1                                   9
HELIX    5   5 VAL A  150  LEU A  156  1                                   7
HELIX    6   6 ASN A  167  ILE A  184  1                                  18
HELIX    7   7 GLN A  185  PHE A  187  5                                   3
HELIX    8   8 SER A  200  SER A  212  1                                  13
HELIX    9   9 SER A  215  PHE A  219  5                                   5
HELIX   10  10 VAL A  238  LEU A  252  1                                  15
HELIX   11  11 SER A  258  LYS A  269  1                                  12
HELIX   12  12 LYS A  270  GLU A  278  1                                   9
HELIX   13  13 TRP A  279  LEU A  282  5                                   4
HELIX   14  14 SER A  304  GLY A  312  1                                   9
HELIX   15  15 GLY A  328  ALA A  336  1                                   9
HELIX   16  16 SER A  348  VAL A  360  1                                  13
HELIX   17  17 ASN A  364  THR A  376  1                                  13
HELIX   18  18 ASN A  383  VAL A  400  1                                  18
HELIX   19  19 VAL A  400  LYS A  413  1                                  14
HELIX   20  20 PRO A  433  GLY A  437  5                                   5
HELIX   21  21 GLU A  443  PHE A  448  1                                   6
HELIX   22  22 GLY A  449  ASN A  457  5                                   9
HELIX   23  23 THR A  459  GLY A  480  1                                  22
HELIX   24  24 ARG A  517  GLN A  526  1                                  10
HELIX   25  25 GLN A  526  THR A  535  1                                  10
SHEET    1   A 3 LEU A   7  THR A  10  0
SHEET    2   A 3 GLY A  13  MET A  16 -1  O  VAL A  15   N  VAL A   8
SHEET    3   A 3 VAL A  57  ASN A  59  1  O  TRP A  58   N  MET A  16
SHEET    1   B11 THR A  18  VAL A  22  0
SHEET    2   B11 SER A  25  PRO A  34 -1  O  ILE A  27   N  VAL A  20
SHEET    3   B11 TYR A  96  VAL A 101 -1  O  ILE A  99   N  PHE A  30
SHEET    4   B11 VAL A 142  SER A 145 -1  O  SER A 145   N  ASN A  98
SHEET    5   B11 THR A 109  ILE A 115  1  N  TRP A 114   O  VAL A 144
SHEET    6   B11 GLY A 189  GLU A 199  1  O  THR A 195   N  VAL A 113
SHEET    7   B11 ARG A 221  GLN A 225  1  O  GLN A 225   N  GLY A 198
SHEET    8   B11 GLN A 318  ASN A 324  1  O  LEU A 320   N  LEU A 224
SHEET    9   B11 GLY A 417  PHE A 423  1  O  PHE A 423   N  VAL A 323
SHEET   10   B11 LYS A 501  LEU A 505  1  O  LEU A 505   N  PHE A 422
SHEET   11   B11 VAL A 512  GLN A 514 -1  O  HIS A 513   N  PHE A 502
SHEET    1   C 2 VAL A 236  SER A 237  0
SHEET    2   C 2 VAL A 295  ILE A 296  1  O  ILE A 296   N  VAL A 236
SSBOND   1 CYS A   67    CYS A   94
SSBOND   2 CYS A  254    CYS A  265
SSBOND   3 CYS A  402    CYS A  521
LINK         ND2 ASN A  59                 C1  NAG A1059
LINK         ND2 ASN A 416                 C1  NAG A1416
LINK         OG  SER A 200                 C7  GSG A1200
CISPEP   1 SER A  103    PRO A  104          0         0.35
CRYST1  111.736  111.736  136.824  90.00  90.00 120.00 P 31 2 1      6
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.008950  0.005167  0.000000        0.00000
SCALE2      0.000000  0.010334  0.000000        0.00000
SCALE3      0.000000  0.000000  0.007309        0.00000
TER    4245      THR A 535
MASTER      324    0    6   25   16    0    0    6 4597    1   88   42
END